1-5 of 5
William Janssen, PhD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Lentiviral Gene Therapy with Low Dose Busulfan for Infants with X-SCID Results in the Development of a Functional Normal Immune System: Interim Results of an Ongoing Phase I/II Clinical Study

Ewelina Mamcarz, MD, Sheng Zhou, PhD, Timothy Lockey, PhD, Shannon Boi, PhD, Yan Koon-Kiu, PhD, Shane Cross, Pharm.D., Guolian Kang, PhD, Zhijun Ma, MD, Jose Marcos Condori, PhD, Jolanta Dowdy, M.S., Jean-Yves Metais, PhD, Deanna Langfitt, PhD, Brandon Triplett, MD, Chen Li, M.S., Xiwen Zhao, MSPH, Gabriela Maron, MD, Sneha Suresh, MD, Juan Carlos Aldave Becerra, MD, Joseph Church, MD, Elif Dokmeci, MD, James T Love, MD, PhD, Hedi van der Watt, MD, Ana C da Matta Ain, MD, Christa Krupski, DO, MPH, Jiyang Yu, PhD, Lance E. Palmer, PhD, William Janssen, PhD, Suk See De Ravin, MD, PhD, Mitchell J. Weiss, MD, PhD, Benjamin Youngblood, PhD, Janel R Long-Boyle, PharmD, PhD, Michael M Meagher, PhD, Harry L. Malech, MD, Jennifer Puck, MD, Morton J Cowan, MD, Stephen Gottschalk, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 2058.
https://doi.org/10.1182/blood-2019-126746
Published: 2019
Journal Articles

Allogeneic Hematopoietic Cell Transplantation (HCT) for Myelodysplastic Syndrome (MDS) after Pretransplant 5-Azacitidine.

Teresa Field, MD, PhD, Melissa Alsina, MD, Ernesto Ayala, MD, Hugo Fernandez, MD, William Janssen, PhD, Mohammed Karfan-Dabaja, MD, Jeffery Lancet, MD, Mafda Melchert, MD, Jyoti Raychaudhuri, MD, Daniel Sullivan, MD, Alan List, MD, Claudio Anasetti, MD, William Poling, PhD, Janelle Perkins, PharmD
Journal: Blood
Blood (2007) 110 (11): 5035.
https://doi.org/10.1182/blood.V110.11.5035.5035
Published: 2007
Journal Articles

Pre-Transplant 5-Azacitidine (Vidaza®) May Improve Outcome of Allogeneic Hematopoietic Cell Transplantation (HCT) in Patients with Myelodysplastic Syndrome (MDS).

Teresa Field, MD, PhD, Janelle Perkins, PharmD, Melissa Alsina, MD, Ernesto Ayala, MD, Hugo F. Fernandez, MD, William Janssen, PhD, Mohamed Kharfan-Dabaja, MD, Jeffery Lancet, MD, Lia Perez, MD, Daniel Sullivan, MD, Alan List, MD, Claudio Anasetti, MD
Journal: Blood
Blood (2006) 108 (11): 3664.
https://doi.org/10.1182/blood.V108.11.3664.3664
Published: 2006
Journal Articles

Busulfan Area-under-the-Curve Finding Study within a Busulfan/Fludarabine (BuFlu) Conditioning Regimen before Allogeneic Hematopoietic Cell Transplantation (HCT).

Teresa Field, MD, PhD, Janelle Perkins, PharmD, Melissa Alsina, MD, Ernesto Ayala, MD, Karen Fancher, PharmD, Hugo F. Fernandez, MD, Dawn Garrett, LPN, William Janssen, PhD, Mohamed Kharfan-Dabaja, MD, Lia Perez, MD, Daniel Sullivan, MD, Cheryl Tate, PharmD, Claudio Anasetti, MD
Journal: Blood
Blood (2006) 108 (11): 2939.
https://doi.org/10.1182/blood.V108.11.2939.2939
Published: 2006
Journal Articles

Targeted Intravenous Busulfan Combined with Fludarabine (tBuFlu) as Conditioning Prior to Allogeneic Peripheral Blood Stem Cell Transplant: Early Results of Low Treatment Related Mortality.

Teresa Field, MD, PhD, Janelle Perkins, PharmD, Melissa Alsina, MD, Ernesto Ayala, MD, Karen Fancher, PharmD, William Janssen, PhD, Lia Perez, MD, Daniel Sullivan, MD, Cheryl Tate, PharmD, Claudio Anasetti, MD
Journal: Blood
Blood (2005) 106 (11): 1759.
https://doi.org/10.1182/blood.V106.11.1759.1759
Published: 2005